3 ASX Stocks Slip as September Quarterly Reports Land

Sonal Goyal

27 October 2026 04:27 PM AEDT

3 ASX Stocks Slip as September Quarterly Reports Land

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Strategic Energy Resources (ASX:SER) traded at $0.175, down 12.50%. Diamond drilling of more than 1,500 m began at Canobie, funded by Fortescue.
Phosco (ASX:PHO) traded at $0.135, down 10.00%. Phosco signed an MOU with STUDI International, which will invest $1.4 million at $0.15 per share.
Global Health (ASX:GLH) traded at $0.055, down 8.33%. Operating Cash Flow improved by $237,000, or 22%, to an outflow of $828,000.

Shares in Strategic Energy Resources Ltd (ASX:SER), Phosco Ltd (ASX:PHO) and Global Health Ltd (ASX:GLH) were trading lower during the 27 October 2026 trading session: Strategic Energy Resources at $0.175, down 12.50%; Phosco at $0.135, down 10.00%; Global Health at $0.055, down 8.33%. At the same time, the S&P/ASX 200 index was at 8,852.80, up 0.49% (42.90 points), at 3:40 pm GMT+11. Three companies that released September quarterly reports on or around 27 October 2026 traded lower.

Strategic Energy Resources Ltd (ASX:SER)

Strategic Energy Resources shares traded at $0.175, down 12.50%, during the session. SER reported back-to-back Queensland drilling programs, completion of the Diamantina Acquisition from Anglo American and a $1.7 million Capital raising. The announcement is dated 27 October 2026.

Phosco Ltd (ASX:PHO)

Phosco shares traded at $0.135, down 10.00%, during the session. Phosco reported thick phosphate at the KH prospect, a new Sekarna North discovery, a STUDI International Partnership with a $1.4 million Investment and A$3.8 million in cash. The announcement is dated 27 October 2026.

Global Health Ltd (ASX:GLH)

Global Health shares traded at $0.055, down 8.33%, during the session. Global Health reported a 22% improvement in operating cash outflow to $828,000 for the September quarter and over $1.6 million received in October.

Sector Context

The broader market was higher during the session, with the S&P/ASX 200 index was at 8,852.80, up 0.49% (42.90 points), at 3:40 pm GMT+11. Copper and copper-gold explorers and producers report drilling, shipments and funding in stages, and results are announced as assays and sales are finalised.

Risks

Items noted in the companies’ materials include Drill results are pending for all three programs; the US funding opportunity would be awarded to third parties, and Phosco’s role would be as a counterparty asset; the quarter still shows an operating cash outflow, and cash collections vary by quarter.

What Lies Ahead

The documents point to the following next steps: for Strategic Energy Resources, assays from Canobie and Bulimba and the late-October start of drilling at Diamantina; for Phosco, the updated Scoping Study, the Pre-Feasibility and Bankable Feasibility Studies and the US Notice of Funding Opportunity process; for Global Health, deal decisions in the December and March quarters and large projects going live between May and November.

Wrapping Up

SER, PHO and GLH fell during the session. Their quarterly reports cover drilling, studies and cash flow.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.